Your browser doesn't support javascript.
loading
Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.
Peng, X; Sun, P; Novick, D; Andrews, J; Sun, S.
Affiliation
  • Peng X; Eli Lilly and Company, Indianapolis, IN, USA.
  • Sun P; Kailo Research Group, Indianapolis, IN, USA.
  • Novick D; Eli Lilly and Company, Indianapolis, IN, USA.
  • Andrews J; Eli Lilly and Company, Indianapolis, IN, USA.
  • Sun S; Kailo Research Group, Indianapolis, IN, USA.
J Pain Res ; 7: 37-46, 2014.
Article in En | MEDLINE | ID: mdl-24470771
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Aspects: Implementation_research Language: En Journal: J Pain Res Year: 2014 Document type: Article Affiliation country: United States Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Aspects: Implementation_research Language: En Journal: J Pain Res Year: 2014 Document type: Article Affiliation country: United States Country of publication: New Zealand